| 2022-06-01 |
股东大会：
将于2022-06-28召开股东大会
会议内容 ▼▲
- 1.To receive and adopt the Company’s annual accounts for the financial year ended 31 December 2021, together with the Directors’ Report and the Auditor’s Report thereon.
2.The Directors’ Remuneration Report for the financial year ended 31 December 2021, as set out on pages 45 to 50 of the Annual Report and Accounts for the financial year ended 31 December 2021, is to be approved. This will be an advisory vote.
3.In addition, the Directors’ Remuneration Policy set out on pages 36 to 44 of the Annual Report and Accounts for the financial year ended 31 December 2021 is to be approved. This is a binding vote and, if passed, will mean that the Company can only make remuneration payments to Directors in accordance with the approved policy which, unless amended, will require shareholder approval every three years.
4.In accordance with the Company’s articles of association, the Directors must seek re-election on a regular basis, including in particular those Directors who have served longest in office since their last appointment. Sandy Macrae and Alex Stevenson are therefore putting themselves up for re-election at the AGM.
5.The Board of Directors, on the recommendation of its Audit and Risk Committee, recommends the re-appointment of RSM UK Audit LLP as auditor, to hold office until the next general meeting at which accounts are laid before the shareholders.
6.This resolution authorises the Directors to agree the auditors’ remuneration.
7.Resolution 8 will, if approved, provide the Directors with authority to allot shares in the Company or to grant rights to subscribe for, or to convert any security into, shares in the Company. This authority, which will expire at the earlier of the conclusion of the Annual General Meeting of the Company to be held in 2023 or 30 September 2023, is limited to the allotment of shares up to an aggregate nominal amount of ￡450,752 (representing approximately 100 per cent. of the Company’s issued ordinary share capital as at the date of the Notice of AGM).
8.Resolution 9 will, if approved, provide the Directors with authority to allot equity securities (as defined in the Companies Act 2006) for cash and otherwise than to existing shareholders pro rata to their holdings. This authority, which will expire at the earlier of the conclusion of the Annual General Meeting of the Company to be held in 2023 or 30 September 2023, is limited to the allotment of equity securities up to an aggregate nominal amount of ￡450,752 (representing approximately 100 per cent of the Company’s issued ordinary share capital as at the date of the Notice of AGM).
|
| 2022-03-31 |
详情>>
业绩披露：
2021年年报每股收益-0.19美元,归母净利润-3193.8万美元,同比去年增长-4.73%
|
| 2021-09-30 |
详情>>
股本变动：
变动后总股本18030.10万股
变动原因 ▼▲
- 原因：
- 20201231-20210630
已行使认股权证
已行使的购股权
于2021年3月22日作为合并的一部分发行
2021年3月22日配售
2021年4月16日的董事认购
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-01 |
股东大会：
将于2021-05-24召开股东大会
|
| 2021-02-26 |
股东大会：
将于2021-03-17召开股东大会
会议内容 ▼▲
- 1.The Longevity Merger Proposal — To approve the BVI Plan of Merger, the Merger Agreement and the Merger contemplated thereby.
2.The Longevity Adjournment Proposal — To consider and vote upon a proposal to adjourn the Longevity Special Meeting to a later date or dates, if necessary to permit further solicitation and vote of proxies if it is determined by Longevity that more time is necessary or appropriate to approve one or more proposals presented at the Longevity Special Meeting. This proposal is referred to as the “Longevity Adjournment Proposal” and, together with the Longevity Merger Proposal, as the “Longevity Proposals.”
|
| 2021-01-13 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-0.27美元,归母净利润-54.01万美元,同比去年增长28.38%
|
| 2020-12-28 |
复牌提示：
2020-12-28 10:12:44 停牌，复牌日期 2020-12-28 10:17:44
|
| 2020-12-03 |
股东大会：
将于2020-12-18召开股东大会
会议内容 ▼▲
- 1.To re-elect each of the two directors identified herein to the Company’s board of directors (the “Board”), with such directors to serve until the 2021 annual meeting of shareholders;
2.To ratify the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the year ended February 29, 2020 and for the periods ended May 31, 2020 and August 31, 2020;
3.To direct the chairman of the Meeting to adjourn the Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Meeting, there are not sufficient votes to approve any of the foregoing proposals.
|
| 2020-10-26 |
股东大会：
将于2020-11-20召开股东大会
会议内容 ▼▲
- 1.a proposal to amend Longevity’s amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”) to extend the date by which Longevity must consummate a business combination (the “Extension”) from November 30, 2020 to May 29, 2021, or such earlier date as determined by the Board (the “Extended Date”), by amending the Amended and Restated Memorandum and Articles of Association to delete the existing Regulation 23.2 thereof and replacing it with the new Regulation 23.2 in the form set forth in Annex A (the “Extension Proposal”);
2.a proposal to direct the chairman of the special meeting to adjourn the special meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the special meeting, there are not sufficient votes to approve the Extension Proposal (the “Adjournment Proposal”).
|
| 2020-10-07 |
详情>>
业绩披露：
2021年中报每股收益-0.17美元,归母净利润-34.11万美元,同比去年增长97.69%
|
| 2020-07-09 |
详情>>
业绩披露：
2021年一季报每股收益-0.08美元,归母净利润-16.06万美元,同比去年增长22.81%
|
| 2020-07-09 |
详情>>
业绩披露：
2020年一季报每股收益-0.12美元,归母净利润-20.81万美元,同比去年增长-8753.53%
|
| 2020-05-01 |
股东大会：
将于2020-05-22召开股东大会
会议内容 ▼▲
- 1.a proposal to amend Longevity’s amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”) to extend the date by which Longevity must consummate a business combination (the “Extension”) from May 29, 2020 to November 30, 2020 (the “Extended Date”), by amending the Amended and Restated Memorandum and Articles of Association to delete the existing Regulation 23.2 thereof and replacing it with the new Regulation 23.2 in the form set forth in Annex A (the “Extension Proposal”);
2.a proposal to elect each of Messrs. Jun Liu and Pai Liu as Class I directors of the Company (the “Director Proposal”);
3.a proposal to direct the chairman of the special meeting to adjourn the special meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the special meeting, there are not sufficient votes to approve the Extension Proposal (the “Adjournment Proposal”).
|
| 2020-04-30 |
详情>>
业绩披露：
2019年年报每股收益-0.25美元,归母净利润-38.34万美元,同比去年增长98.82%
|
| 2020-04-30 |
详情>>
业绩披露：
2020年年报每股收益-0.5美元,归母净利润-93.71万美元,同比去年增长96.91%
|
| 2020-01-10 |
详情>>
业绩披露：
2020年三季报(累计)每股收益-0.41美元,归母净利润-75.41万美元,同比去年增长-280.96%
|
| 2019-10-16 |
详情>>
业绩披露：
2020年中报每股收益-0.28美元,归母净利润-50万美元,同比去年增长-7095.85%
|